# Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

> **NCT01165632** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Adult Anaplastic Astrocytoma
- Adult Anaplastic Ependymoma
- Adult Anaplastic Oligodendroglioma
- Adult Brain Stem Glioma
- Adult Diffuse Astrocytoma
- Adult Ependymoma
- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma
- Adult Mixed Glioma
- Adult Myxopapillary Ependymoma
- Adult Oligodendroglioma
- Adult Pilocytic Astrocytoma
- Adult Pineal Gland Astrocytoma
- Adult Subependymal Giant Cell Astrocytoma
- Adult Subependymoma

## Interventions

- **PROCEDURE:** biopsy
- **PROCEDURE:** computed tomography
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** radiation therapy treatment planning/simulation
- **RADIATION:** radiation therapy
- **PROCEDURE:** magnetic resonance imaging
- **PROCEDURE:** positron emission tomography
- **DRUG:** fluorine F 18 fluorodopa

## Key facts

- **NCT ID:** NCT01165632
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-26
- **Primary completion:** 2013-11-05
- **Final completion:** 2019-07-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165632, "Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01165632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*